Effect of switching from tiotropium to glycopyrronium on pulmonary function in patients with COPD.
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease(COPD)
- Registration Number
- JPRN-UMIN000015244
- Lead Sponsor
- KKR Takamatsu hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)patients who need systemic corcicosteroidal administration and/or hospitalization for COPD exacerbation within 16 weeks prior to enrollment 2)patients having lower respiratory infection within 16weeks prior to enrollment 3)patients with home oxygen therapy 4)patients with bronchial asthma or chronic respiratory disease such as bronchiectasis,pulmonary fibrosis and pneumoconiosis 5)patients with uncontrolled severe complications 6)patients who seem inadequate for this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1.0 respiratory resistance index(R5,R20,R5-20,X5,Fres)
- Secondary Outcome Measures
Name Time Method CAT score